ARVINAS, INC. Increase (Decrease) in Other Receivables
ARVINAS, INC. (ARVN) reported Increase (Decrease) in Other Receivables of -$1.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-04
- ARVINAS, INC. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$600.00K, a 123.08% decline year-over-year.
- ARVINAS, INC. increase (decrease) in other receivables for the quarter ending 2026-03-31 was -$800.00K.
- ARVINAS, INC. increase (decrease) in other receivables for the quarter ending 2025-12-31 was -$1.10M, a 320.00% decline year-over-year.
- ARVINAS, INC. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$4.10M.
- ARVINAS, INC. increase (decrease) in other receivables for fiscal 2025 was -$2.60M, a 425.00% decline from fiscal 2024.
- ARVINAS, INC. increase (decrease) in other receivables for fiscal 2024 was $800.00K, a 300.00% increase from fiscal 2023.
- ARVINAS, INC. increase (decrease) in other receivables for fiscal 2023 was $200.00K.
- ARVINAS, INC. increase (decrease) in other receivables for fiscal 2022 was -$3.70M, a 212.12% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 3 month as first filed | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 6 month as first filed | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 9 month as first filed | Increase (Decrease) in Other Receivables 12 month | Increase (Decrease) in Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.40M 10-Q · filed 2026-08-04 | -$2.50M derived: sum of 3 quarters · filed 2026-08-04 | -$6.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$800.00K 10-Q · filed 2026-05-11 | -$1.90M derived: sum of 2 quarters · filed 2026-05-11 | -$6.00M derived: sum of 3 quarters · filed 2026-05-11 | -$3.40M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$5.20M derived: sum of 2 quarters · filed 2026-02-24 | -$2.60M derived: sum of 3 quarters · filed 2026-08-04 | -$2.60M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.50M derived: sum of 2 quarters · filed 2026-08-04 | -$1.50M 10-Q · filed 2025-11-05 | -$1.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.60M 10-Q · filed 2026-08-04 | $3.10M derived: sum of 3 quarters · filed 2026-08-04 | $600.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $500.00K derived: sum of 2 quarters · filed 2026-05-11 | -$2.00M derived: sum of 3 quarters · filed 2026-05-11 | $900.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$2.00M derived: sum of 2 quarters · filed 2026-02-24 | $900.00K derived: sum of 3 quarters · filed 2026-02-24 | $800.00K 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $400.00K derived: sum of 2 quarters · filed 2025-11-05 | $300.00K 10-Q · filed 2025-11-05 | $2.70M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.80M 10-Q · filed 2025-08-06 | $5.20M derived: sum of 3 quarters · filed 2026-02-24 | $5.40M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$100.00K 10-Q · filed 2025-05-01 | $2.30M derived: sum of 2 quarters · filed 2026-02-24 | $2.50M derived: sum of 3 quarters · filed 2026-02-24 | $2.40M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.60M derived: sum of 2 quarters · filed 2026-02-24 | $2.50M derived: sum of 3 quarters · filed 2026-02-24 | $200.00K 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $100.00K derived: sum of 2 quarters · filed 2024-10-30 | -$2.20M 10-Q · filed 2024-10-30 | -$1.00M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2023-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$2.40M 10-Q · filed 2024-07-30 | -$1.20M derived: sum of 3 quarters · filed 2025-02-11 | -$2.10M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2023-03-31 | -$2.30M 10-Q · filed 2024-05-07 | -$1.10M derived: sum of 2 quarters · filed 2025-02-11 | -$2.00M derived: sum of 3 quarters · filed 2025-02-11 | -$1.90M derived: sum of 4 quarters · filed 2025-02-11 | ||||
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $300.00K derived: sum of 2 quarters · filed 2025-02-11 | $400.00K derived: sum of 3 quarters · filed 2025-02-11 | -$3.70M 10-K · filed 2025-02-11 | ||||
| 2022-09-30 | -$900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$800.00K derived: sum of 2 quarters · filed 2023-11-07 | -$4.90M 10-Q · filed 2023-11-07 | -$900.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$4.00M 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | -$700.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | -$4.10M 10-Q · filed 2023-05-05 | -$100.00K derived: sum of 2 quarters · filed 2024-02-27 | -$800.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.50M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.30M derived: sum of 2 quarters · filed 2024-02-27 | $5.60M derived: sum of 3 quarters · filed 2024-02-27 | $3.30M 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | -$700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.60M derived: sum of 2 quarters · filed 2022-11-09 | -$700.00K 10-Q · filed 2022-11-09 | -$687.93K 10-Q · filed 2021-11-03 | $3.27M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | -$28.04K 10-Q · filed 2021-08-05 | $3.97M derived: sum of 3 quarters · filed 2023-02-23 | $3.92M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | -$2.30M 10-Q · filed 2022-05-05 | -$2.27M 10-Q · filed 2021-05-04 | $1.67M derived: sum of 2 quarters · filed 2023-02-23 | $1.62M derived: sum of 3 quarters · filed 2023-02-23 | $1.30M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.92M derived: sum of 2 quarters · filed 2023-02-23 | $3.60M derived: sum of 3 quarters · filed 2023-02-23 | $1.20M 10-K · filed 2023-02-23 | $1.16M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | -$52.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$366.81K derived: sum of 2 quarters · filed 2021-11-03 | -$2.77M 10-Q · filed 2021-11-03 | -$1.66M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | -$314.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$2.72M 10-Q · filed 2021-08-05 | -$1.60M derived: sum of 3 quarters · filed 2022-02-28 | $2.14M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$2.40M 10-Q · filed 2021-05-04 | -$1.29M derived: sum of 2 quarters · filed 2022-02-28 | $2.45M derived: sum of 3 quarters · filed 2022-02-28 | $1.38M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.85M derived: sum of 2 quarters · filed 2022-02-28 | $3.79M derived: sum of 3 quarters · filed 2022-02-28 | $4.00M 10-K · filed 2022-02-28 | $4.02M 10-K · filed 2020-03-16 | |||
| 2019-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.67M derived: sum of 2 quarters · filed 2020-11-05 | $2.89M 10-Q · filed 2020-11-05 | $2.96M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$853.88K 10-Q · filed 2020-08-04 | -$776.79K derived: sum of 3 quarters · filed 2021-03-01 | -$560.34K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $213.55K 10-Q · filed 2020-04-28 | $290.64K derived: sum of 2 quarters · filed 2021-03-01 | $507.09K derived: sum of 3 quarters · filed 2021-03-01 | $1.03M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $77.09K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $293.54K derived: sum of 2 quarters · filed 2021-03-01 | $821.09K derived: sum of 3 quarters · filed 2021-03-01 | $1.22M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $216.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $744.00K derived: sum of 2 quarters · filed 2019-11-04 | $1.14M 10-Q · filed 2019-11-04 | $1.66M derived: sum of 4 quarters · filed 2019-11-04 | ||||
| 2018-06-30 | $527.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $921.97K 10-Q · filed 2019-08-05 | $1.44M derived: sum of 3 quarters · filed 2019-08-05 | |||||
| 2018-03-31 | $394.43K 10-Q · filed 2019-05-09 | $912.53K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | $518.11K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$369.73K 10-K · filed 2019-03-26 | ||||||
| 2017-09-30 | -$887.84K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |